It has been active in the stem cell research field since 1994, principally focused on technologies to grow, differentiate, select and purify embryonic stem cells. The company now has a substantial portfolio of patents and patent applications within these areas. These include technologies to permit the generation and genetic selection of unlimited quantities of highly purified stem cells and their differentiated progeny for use in genetic, pharmacological and toxicological screens. Moreover, these technologies can be utilised to provide pure populations of appropriate cell types for transplantation therapies.
SCS prides itself with the relationship it has with its academic partners which has placed SCS at the forefront of embryonic stem cell research. Stem Cell Sciences has a long established track record in securing research and licensing deals with International Biotechnology and Pharmaceutical companies.